NASDAQ: MDXG       Mimedx Group Inc
Last Price Today's Change   Day's Range   Trading Volume
9.285   +0.155 (1.70%)  9.04 - 9.30  84,637


Avg Volume (4 weeks):1,292,116
4 Weeks Range:8.65 - 10.51
4 Weeks Price Volatility (%):
52 Weeks Range:5.32 - 10.51
52 Weeks Price Volatility (%):
Average Price Target: 11.00
Price Target Upside/Downside: +1.715


No recent Headlines for this stock.

Business Background

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from human amniotic membrane and birth tissues and human skin and bone. Its products are primarily targeted toward the wound-care, surgical, sports medicine, and orthopedics markets. MiMedx’s key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. It also sells OrthoFlo, an allograft derived from amniotic fluid. In addition, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2606  3408  612  3253 

Top 10 Active Counters
 SNDL 0.746+0.056 
 LK 1.38+1.38 
 WPX 9.43+0.48 
 BNGO 8.95+2.00 
 AVGR 1.62+0.51 
 HTZ 0.00-1.75 
 BB 11.13+2.02 
 GPOR 0.1380.00 
 CTRM 0.344-0.016 
 AMTD 39.97-0.85 


1. Impeachment, Stimulus And The Markets Wall Street Breakfast
2. Daily Futures Trading Strategy 15 January 2021 Where Futures Lies
3. Equities Retreated on Waning Optimism State of The Markets
4. CryptoNews of the Week CryptoNews
5. Wall Street Breakfast: Who Won The Trade War? Wall Street Breakfast